First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Clinical trial NCT06043817 · RECRUITING
Trial details
- NCT number
- NCT06043817
- Sponsor
- Pierre Fabre Medicament
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-26
- Primary completion
- 2029-12-01
- Enrollment
- 345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.